Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5901)
All Articles published online
|
Jun 15, 2011 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Pathophysiology
ISSN
2150-5330
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Francesco VD, Zullo A, Hassan C, Giorgio F, Rosania R, Ierardi E. Mechanisms of |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v2/i3/35.htm |
| Number | Citing Articles |
| 1 |
Se-Won Lee, Jeong Ho Lee. Anti-inflammatory and anti-Helicobacter effects of the Aralia elata hot-water extract. Korean Journal of Food Preservation 2021; 28(2): 279 doi: 10.11002/kjfp.2021.28.2.279
|
| 2 |
Ilaria Maria Saracino, Giulia Fiorini, Angelo Zullo, Matteo Pavoni, Laura Saccomanno, Dino Vaira. Trends in Primary Antibiotic Resistance in H. pylori Strains Isolated in Italy between 2009 and 2019. Antibiotics 2020; 9(1): 26 doi: 10.3390/antibiotics9010026
|
| 3 |
Ana Bačić, Vladimir Milivojević, Isidora Petković, Dušan Kekić, Ina Gajić, Branislava Medić Brkić, Dušan Popadić, Tomica Milosavljević, Mirjana Rajilić-Stojanović. In Search for Reasons behind Helicobacter pylori Eradication Failure–Assessment of the Antibiotics Resistance Rate and Co-Existence of Helicobacter pylori with Candida Species. Journal of Fungi 2023; 9(3): 328 doi: 10.3390/jof9030328
|
| 4 |
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez, F. Bosques-Padilla. Empiric treatment vs susceptibility-guided treatment for eradicating H. pylori: Is it possible to change that paradigm using modern molecular methods?. Revista de Gastroenterología de México (English Edition) 2022; 87(3): 330 doi: 10.1016/j.rgmxen.2022.06.003
|
| 5 |
Ramganesh Selvarajan, Chinedu Obize, Timothy Sibanda, Akebe Luther King Abia, Haijun Long. Evolution and Emergence of Antibiotic Resistance in Given Ecosystems: Possible Strategies for Addressing the Challenge of Antibiotic Resistance. Antibiotics 2022; 12(1): 28 doi: 10.3390/antibiotics12010028
|
| 6 |
Nazlı Arslan, Özlem Yılmaz, Ebru Demiray-Gürbüz. Importance of antimicrobial susceptibility testing for the management of eradication in <i>Helicobacter pylori</i> infection. World Journal of Gastroenterology 2017; 23(16): 2854-2869 doi: 10.3748/wjg.v23.i16.2854
|
| 7 |
Joana S. Vital, Luís Tanoeiro, Ricardo Lopes-Oliveira, Filipa F. Vale. Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data. Biomolecules 2022; 12(5): 691 doi: 10.3390/biom12050691
|
| 8 |
Nuno Almeida, José M. Romãozinho, Maria M. Donato, Cristina Luxo, Olga Cardoso, Maria A. Cipriano, Carol Marinho, Carlos Sofia. Triple Therapy with High‐Dose Proton‐Pump Inhibitor, Amoxicillin, and Doxycycline Is Useless for Helicobacter pylori Eradication: A Proof‐of‐Concept Study. Helicobacter 2014; 19(2): 90 doi: 10.1111/hel.12106
|
| 9 |
Ayla Debraekeleer, Han Remaut. Future perspective for potential Helicobacter pylori eradication therapies. Future Microbiology 2018; 13(6): 671 doi: 10.2217/fmb-2017-0115
|
| 10 |
Paweł Krzyżek. Toxin-Antitoxin Systems - A New Player in Morphological Transformation of Antibiotic-Exposed Helicobacter pylori?. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.670677
|
| 11 |
Shamshul Ansari, Yoshio Yamaoka. Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance. Clinical Microbiology Reviews 2022; 35(3) doi: 10.1128/cmr.00258-21
|
| 12 |
Luong Thi My Ngan, Joon-Kwan Moon, Takayuki Shibamoto, Young-Joon Ahn. Growth-Inhibiting, Bactericidal, and Urease Inhibitory Effects of Paeonia lactiflora Root Constituents and Related Compounds on Antibiotic-Susceptible and -Resistant Strains of Helicobacter pylori. Journal of Agricultural and Food Chemistry 2012; 60(36): 9062 doi: 10.1021/jf3035034
|
| 13 |
Xiang Peng, Huang-wei Chen, Yu Wan, Pei-zhu Su, Jing Yu, Jun-jun Liu, Yi Lu, Min Zhang, Jia-Yin Yao, Min Zhi. Combination of vonoprazan and amoxicillin as the first-line Helicobacter pylori eradication therapy: a multicenter, prospective, randomized, parallel-controlled study. Clinical and Experimental Medicine 2023; 23(7): 4011 doi: 10.1007/s10238-023-01074-5
|
| 14 |
Camelia Quek, Son T. Pham, Kieu T. Tran, Binh T. Pham, Loc V. Huynh, Ngan B.L. Luu, Thao K.T. Le, Kelly Quek, Van H. Pham. Antimicrobial susceptibility and clarithromycin resistance patterns of Helicobacter pylori clinical isolates in Vietnam. F1000Research 2016; 5: 671 doi: 10.12688/f1000research.8239.1
|
| 15 |
Fayaz Ahmad Wani, Gulnaz Bashir, Mushtaq Ahmad Khan, Showkat Ali Zargar, Zubaida Rasool, Qurteeba Qadri. Antibiotic Resistance in Helicobacter pylori: A Mutational Analysis from a Tertiary Care Hospital in Kashmir, India. Indian Journal of Medical Microbiology 2018; 36(2): 265 doi: 10.4103/ijmm.IJMM_18_19
|
| 16 |
A.J. Matta, D.C. Zambrano, Y.C. Martínez, F.F. Fernández. Point mutations in the glycosyltransferase domain of the pbp1a gene in amoxicillin-resistant Helicobacter pylori isolates. Revista de Gastroenterología de México (English Edition) 2023; 88(2): 100 doi: 10.1016/j.rgmxen.2021.05.015
|
| 17 |
A.J. Matta, D.C. Zambrano, Y.C. Martínez, F.F. Fernández. Mutaciones puntuales en el dominio transglicosilasa del gen pbp1a en aislados de Helicobacter pylori resistentes a amoxicilina. Revista de Gastroenterología de México 2023; 88(2): 100 doi: 10.1016/j.rgmx.2021.05.008
|
| 18 |
Mutita Wongsuwanlert, Rawee Teanpaisan, Praphansri Ruangsri, Apichat Kaewdech, Somkiat Sunpaweravong, Nuntiya Pahumunto. Effect of mouthwash containing poly l-Lysine and glycerol monolaurate on oral Helicobacter pylori relating to biofilm eradication, anti-adhesion, and pro-inflammatory cytokine suppression. Journal of Dental Sciences 2023; doi: 10.1016/j.jds.2023.10.010
|
| 19 |
Yong Hwan Kwon, Seong Woo Jeon, Su Youn Nam, Hyun Suk Lee, Ji Hey Park. Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single‐center prospective pilot study. Helicobacter 2019; 24(4) doi: 10.1111/hel.12585
|
| 20 |
Hyun-Kyung Lee, Ha Eun Song, Haeng-Byung Lee, Cheol-Soo Kim, Mamoru Koketsu, Luong Thi My Ngan, Young-Joon Ahn, Dipshikha Chakravortty. Growth Inhibitory, Bactericidal, and Morphostructural Effects of Dehydrocostus Lactone from Magnolia sieboldii Leaves on Antibiotic-Susceptible and -Resistant Strains of Helicobacter pylori. PLoS ONE 2014; 9(4): e95530 doi: 10.1371/journal.pone.0095530
|
| 21 |
Ali Baradaran Moghaddam, Nour Amirmozafari, Shahla Mansouri, Nastaran Farzi, Naser Ebrahimi-Daryani, Masoud Alebouyeh, Mohammad Reza Zali. Nitazoxanide and Doxycycline Sensitivity Among Metronidazole Resistant Helicobacter pylori Isolates from Patients with Gastritis. Archives of Clinical Infectious Diseases 2018; 13(1) doi: 10.5812/archcid.66693
|
| 22 |
Francis Lauener, Frank Imkamp, Philippe Lehours, Alice Buissonnière, Lucie Benejat, Reinhard Zbinden, Peter Keller, Karoline Wagner. Genetic Determinants and Prediction of Antibiotic Resistance Phenotypes in Helicobacter pylori. Journal of Clinical Medicine 2019; 8(1): 53 doi: 10.3390/jcm8010053
|
| 23 |
Divya S. Raj, Dinesh Kumar Kesavan, Natarajan Muthusamy, S. Umamaheswari. Efflux pumps potential drug targets to circumvent drug Resistance – Multi drug efflux pumps of Helicobacter pylori. Materials Today: Proceedings 2021; 45: 2976 doi: 10.1016/j.matpr.2020.11.955
|
| 24 |
Steven F. Moss, Long P. Dang, David Chua, Javier Sobrado, Yi Zhou, David Y. Graham. Comparable Results of Helicobacter pylori Antibiotic Resistance Testing of Stools vs Gastric Biopsies Using Next-Generation Sequencing. Gastroenterology 2022; 162(7): 2095 doi: 10.1053/j.gastro.2022.02.027
|
| 25 |
L.F. Garrido-Treviño, M. López-Martínez, J.A. Flores-Hinojosa, L. Tijerina-Rodríguez, F. Bosques-Padilla. Tratamiento empírico vs tratamiento basado en susceptibilidad para erradicar H.pylori: ¿es posible cambiar este paradigma usando métodos moleculares modernos?. Revista de Gastroenterología de México 2022; 87(3): 330 doi: 10.1016/j.rgmx.2022.01.007
|
| 26 |
Dalia Hamza, Rehab Elhelw, Mahmoud Elhariri, Eman Ragab. Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance. Microbial Pathogenesis 2018; 123: 330 doi: 10.1016/j.micpath.2018.07.016
|
| 27 |
Sandra Salillas, Juan José Galano-Frutos, Alejandro Mahía, Ritwik Maity, María Conde-Giménez, Ernesto Anoz-Carbonell, Helena Berlamont, Adrian Velazquez-Campoy, Eliette Touati, Uwe Mamat, Ulrich E. Schaible, José A. Gálvez, María D. Díaz-de-Villegas, Freddy Haesebrouck, José A. Aínsa, Javier Sancho. Selective Targeting of Human and Animal Pathogens of the Helicobacter Genus by Flavodoxin Inhibitors: Efficacy, Synergy, Resistance and Mechanistic Studies. International Journal of Molecular Sciences 2021; 22(18): 10137 doi: 10.3390/ijms221810137
|
| 28 |
Dana Binyamin, Nina Pastukh, Avi On, Maya Paritsky, Avi Peretz. Phenotypic and genotypic correlation as expressed in Helicobacter pylori resistance to clarithromycin and fluoroquinolones. Gut Pathogens 2017; 9(1) doi: 10.1186/s13099-017-0198-5
|
| 29 |
S. Yu. Serebrova, E. N. Kareva, N. N. Eremenko, A. B. Prokof’ev, D. O. Kurguzova, V. N. Drozdov, N. B. Lazareva, I. A. Komissarenko, A. K. Starodubtsev. Role of Drug – Drug Interactions in the Efficacy and Safety of Clarithromycin Treatment for Helicobacter Pylori Eradication. Pharmaceutical Chemistry Journal 2019; 53(8): 678 doi: 10.1007/s11094-019-02061-5
|
| 30 |
Hong-xin Zhang, Yu-yu Qiu, Ying-hui Zhao, Xin-ting Liu, Ming Liu, Ai-lian Yu. Immunogenicity of oral vaccination with Lactococcus lactis derived vaccine candidate antigen (UreB) of Helicobacter pylori fused with the human interleukin 2 as adjuvant. Molecular and Cellular Probes 2014; 28(1): 25 doi: 10.1016/j.mcp.2013.08.003
|
| 31 |
Saracino I.M., Pavoni M., Zullo A., Fiorini G., Saccomanno L., Lazzarotto T., Cavallo R., Antonelli G., Vaira D.. Antibiotic Resistance and Therapy Outcome in H. pylori Eradication Failure Patients. Antibiotics 2020; 9(3): 121 doi: 10.3390/antibiotics9030121
|
| 32 |
Jiaoe Chen, Liping Ye, Liangmin Jin, Xuehua Xu, Peisong Xu, Xianjun Wang, Hongzhang Li. Application of next-generation sequencing to characterize novel mutations in clarithromycin-susceptible Helicobacter pylori strains with A2143G of 23S rRNA gene. Annals of Clinical Microbiology and Antimicrobials 2018; 17(1) doi: 10.1186/s12941-018-0259-8
|
| 33 |
Éva Kocsmár, György Miklós Buzás, Ildikó Szirtes, Ildikó Kocsmár, Zsófia Kramer, Attila Szijártó, Petra Fadgyas-Freyler, Kató Szénás, Massimo Rugge, Matteo Fassan, András Kiss, Zsuzsa Schaff, Gergely Röst, Gábor Lotz. Primary and secondary clarithromycin resistance in Helicobacter pylori and mathematical modeling of the role of macrolides. Nature Communications 2021; 12(1) doi: 10.1038/s41467-021-22557-7
|
| 34 |
Hye Yoon Park, Eun Jeong Kang, Dong Gun Kim, Ki Ju Kim, Jin Woo Choi, Su Youn Nam, Yong Hwan Kwon, Hyun Seok Lee, Seong Woo Jeon. High and Frequent Dose of Dexlansoprazole and Amoxicillin Dual Therapy for Helicobacter pylori Infections: A Single Arm Prospective Study. Korean Journal of Gastroenterology 2017; 70(4): 176 doi: 10.4166/kjg.2017.70.4.176
|
| 35 |
Judit Alarcón-Millán, José Bonilla-Delgado, Gloria Fernández-Tilapa, Nayeli Goreti Nieto-Velázquez, Mónica Sierra-Martínez, Víctor Manuel Alvarado-Castro, Enoc Mariano Cortés-Malagón. Helicobacter pylori Virulence Factors and Clarithromycin Resistance-Associated Mutations in Mexican Patients. Pathogens 2023; 12(2): 234 doi: 10.3390/pathogens12020234
|
| 36 |
Katherine A. Lyseng-Williamson. Pylera® (bismuth subcitrate potassium/metronidazole/tetracycline hydrochloride) in the eradication of Helicobacter pylori infection: a profile of its use in Europe. Drugs & Therapy Perspectives 2017; 33(7): 311 doi: 10.1007/s40267-017-0417-7
|
| 37 |
Jung Won Lee, Nayoung Kim, Ryoung Hee Nam, Jeong Eun Yu, Joo Hee Son, Sun Min Lee, Dong Ho Lee. Efficacy of Tegoprazan for Improving the Susceptibility of Antimicrobial Agents against Antibiotic-Resistant Helicobacter pylori. Gut and Liver 2021; 15(1): 53 doi: 10.5009/gnl20247
|
| 38 |
Helia Alavifard, Ali Nabavi-Rad, Kaveh Baghaei, Amir Sadeghi, Abbas Yadegar, Mohammad Reza Zali. Pyrosequencing analysis for rapid and accurate detection of clarithromycin resistance-associated mutations in Iranian Helicobacter pylori isolates. BMC Research Notes 2023; 16(1) doi: 10.1186/s13104-023-06420-0
|
| 39 |
Kimberly Sánchez-Alonzo, Luciano Arellano-Arriagada, Susana Castro-Seriche, Cristian Parra-Sepúlveda, Humberto Bernasconi, Héctor Benavidez-Hernández, Víctor L. Campos, Katia Sáez, Carlos T. Smith, Apolinaria García-Cancino. Temperatures Outside the Optimal Range for Helicobacter pylori Increase Its Harboring within Candida Yeast Cells. Biology 2021; 10(9): 915 doi: 10.3390/biology10090915
|
| 40 |
Urszula Zarzecka, Aileen Harrer, Anna Zawilak-Pawlik, Joanna Skorko-Glonek, Steffen Backert. Chaperone activity of serine protease HtrA of Helicobacter pylori as a crucial survival factor under stress conditions. Cell Communication and Signaling 2019; 17(1) doi: 10.1186/s12964-019-0481-9
|
| 41 |
Shahrbanoo Keshavarz Azizi Raftar, Rezvan Moniri, Mahmood Saffari, Mohsen Razavi Zadeh, Abbas Arj, Seyed Gholam Abbas Mousavi, Hamed Mirzaei Ghazi Kalayeh, Kamran Dastehgoli. The Helicobacter pylori Resistance Rate to Clarithromycin in Iran. Microbial Drug Resistance 2015; 21(1): 69 doi: 10.1089/mdr.2014.0104
|
| 42 |
Asif Sukri, Alfizah Hanafiah, Hamidah Yusoff, Nur Atiqah Shamsul Nizam, Zarith Nameyrra, Zhiqin Wong, Raja Affendi Raja Ali. Multidrug-Resistant Helicobacter pylori Strains: A Five-Year Surveillance Study and Its Genome Characteristics. Antibiotics 2022; 11(10): 1391 doi: 10.3390/antibiotics11101391
|
| 43 |
Marwa S. Fathi, Runia Fouad EL-Folly, Rania Ahmed Hassan, Mohammed Ezz El-Arab. Genotypic and phenotypic patterns of antimicrobial susceptibility of Helicobacter pylori strains among Egyptian patients. Egyptian Journal of Medical Human Genetics 2013; 14(3): 235 doi: 10.1016/j.ejmhg.2013.03.004
|
| 44 |
Ilaria Maria Saracino, Matteo Pavoni, Angelo Zullo, Giulia Fiorini, Tiziana Lazzarotto, Claudio Borghi, Dino Vaira. Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review. Antibiotics 2021; 10(4): 437 doi: 10.3390/antibiotics10040437
|
| 45 |
Van Huy Tran, Thi Minh Thi Ha, Phan Tuong Quynh Le, Trung Nam Phan, Thi Nhu Hoa Tran. Characterisation of point mutations in domain V of the 23S rRNA gene of clinical Helicobacter pylori strains and clarithromycin-resistant phenotype in central Vietnam. Journal of Global Antimicrobial Resistance 2019; 16: 87 doi: 10.1016/j.jgar.2018.09.012
|
| 46 |
John Jairo Aguilera-Correa, Pedro Urruzuno, Josefa Barrio, María José Martinez, Sonia Agudo, Angela Somodevilla, Laura Llorca, Teresa Alarcón. Detection of Helicobacter pylori and the genotypes of resistance to clarithromycin and the heterogeneous genotype to this antibiotic in biopsies obtained from symptomatic children. Diagnostic Microbiology and Infectious Disease 2017; 87(2): 150 doi: 10.1016/j.diagmicrobio.2016.03.001
|
| 47 |
Luong Thi My Ngan, Pham Phuong Dung, Nguyen Vang Thi Yen Nhi, Nguyen van Minh Hoang, Tran Trung Hieu. Antibacterial activity of ethanolic extracts of some Vietnamese medicinal plants against Helicobacter pylori. 2017; 1878: 020030 doi: 10.1063/1.5000198
|
| 48 |
Bekir Kocazeybek, Merve Kutlu Sakli, Pelin Yuksel, Mehmet Demirci, Reyhan Caliskan, Tevhide Ziver Sarp, Suat Saribas, Suleyman Demiryas, Fatma Kalayci, Huseyin Cakan, Hayriye Kirkoyun Uysal, Nesrin Gareayaghi, Sevgi Ergin, Yusuf Ziya Erzin, Kadir Bal, İhsan Tascı, Hrisi Bahar Tokman. Comparison of new and classical point mutations associated with clarithromycin resistance in Helicobacter pylori strains isolated from dyspeptic patients and their effects on phenotypic clarithromycin resistance.
Journal of Medical Microbiology
2019; 68(4): 566 doi: 10.1099/jmm.0.000944
|
| 49 |
Yuji Morita, Junko Tomida, Yoshiaki Kawamura. Multidrug Efflux Systems in Helicobacter cinaedi. Antibiotics 2012; 1(1): 29 doi: 10.3390/antibiotics1010029
|
| 50 |
Reyhan Caliskan, Hrisi Bahar Tokman, Yusuf Erzin, Suat Saribas, Pelin Yuksel, Bora Kazim Bolek, Ecehan Ozge Sevuk, Mehmet Demirci, Ozge Yılmazli, Ozer Akgul, Fatma Kalayci, Huseyin Cakan, Barik Salih, Kadir Bal, Bekir Kocazeybek. Antimicrobial resistance of Helicobacter pylori strains to five antibiotics, including levofloxacin, in Northwestern Turkey. Revista da Sociedade Brasileira de Medicina Tropical 2015; 48(3): 278 doi: 10.1590/0037-8682-0027-2015
|
| 51 |
Ji Hae Nahm, Won Kyu Kim, Yujin Kwon, Hyunki Kim. Detection of Helicobacter pylori with clarithromycin resistance‐associated mutations using peptide nucleic acid probe‐based melting point analysis. Helicobacter 2019; 24(5) doi: 10.1111/hel.12634
|
| 52 |
I V Maev, D N Andreev. Molecular genetic predictors of resistance to anti-Helicobacter pylori therapy. Terapevticheskii arkhiv 2017; 89(8): 5 doi: 10.17116/terarkh20178985-12
|
| 53 |
Nina Pastukh, Dana Binyamin, Avi On, Maya Paritsky, Avi Peretz. GenoType® HelicoDR test in comparison with histology and culture for Helicobacter pylori detection and identification of resistance mutations to clarithromycin and fluoroquinolones. Helicobacter 2017; 22(6) doi: 10.1111/hel.12447
|
| 54 |
Alicia C Marín, Adrian G McNicholl, Vincenzo Savarino, Xavier Calvet, Grigorios I Leontiadis, Lori Fischbach, Yuhong Yuan, Javier P Gisbert. Optimum second-line regimens for Helicobacter pylori
eradication. Cochrane Database of Systematic Reviews 2014; doi: 10.1002/14651858.CD011363
|
| 55 |
Judit Alarcón-Millán, Gloria Fernández-Tilapa, Enoc Mariano Cortés-Malagón, Carlos Alberto Castañón-Sánchez, José De Sampedro-Reyes, Iván Cruz-del Carmen, Reyes Betancourt-Linares, Adolfo Román-Román. Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritis. Infection, Genetics and Evolution 2016; 44: 190 doi: 10.1016/j.meegid.2016.06.044
|
| 56 |
Boram Cha, Byoung Wook Bang, Jong Beom Shin, Eun Jung Ko, Weonjin Ko, Kye Sook Kwon, Yong Woon Shin, Young Ju Suh, Hyungkil Kim. Bismuth containing quadruple therapy versus tailored therapy as first-line treatments for Helicobacter pylori infection in a high clarithromycin resistance area. Scandinavian Journal of Gastroenterology 2021; 56(9): 1017 doi: 10.1080/00365521.2021.1948606
|
| 57 |
Vincenzo De Francesco, Cesare Hassan, Lorenzo Ridola, Floriana Giorgio, Enzo Ierardi, Angelo Zullo. Sequential, concomitant and hybrid first-line therapies for Helicobacter pylori eradication: a prospective randomized study.
Journal of Medical Microbiology
2014; 63(5): 748 doi: 10.1099/jmm.0.072322-0
|
| 58 |
N. Almeida, J.M. Romãozinho, M.M. Donato, C. Luxo, O. Cardoso, M.A. Cipriano, C. Marinho, A. Fernandes, C. Calhau, C. Sofia. Helicobacter pylori antimicrobial resistance rates in the central region of Portugal. Clinical Microbiology and Infection 2014; 20(11): 1127 doi: 10.1111/1469-0691.12701
|
| 59 |
Jung Won Lee, Nayoung Kim, Ryoung Hee Nam, Ji Hyun Park, Yoon Jin Choi, Jung Mogg Kim, Joo Sung Kim, Hyun Chae Jung. GenoType HelicoDR test in the determination of antimicrobial resistance ofHelicobacter pyloriin Korea. Scandinavian Journal of Gastroenterology 2014; 49(9): 1058 doi: 10.3109/00365521.2014.894117
|
| 60 |
Vignesh Shetty, Binit Lamichhane, Chin Yen Tay, Ganesh C. Pai, Ramachandra Lingadakai, Girisha Balaraju, Shiran Shetty, Mamatha Ballal, Eng Guan Chua. High primary resistance to metronidazole and levofloxacin, and a moderate resistance to clarithromycin in Helicobacter pylori isolated from Karnataka patients. Gut Pathogens 2019; 11(1) doi: 10.1186/s13099-019-0305-x
|
| 61 |
I.A. Egorov, T.A. Egorova, E.A. Yildirim, K.A. Kalitkina, L.A. Ilina, V.G. Frolov, S. Eliseeva, E.A. Vatskel. Effect of chitosan complexes on the bacterial community of cecum and productivity of broiler chickens. BIO Web of Conferences 2022; 48: 03007 doi: 10.1051/bioconf/20224803007
|
| 62 |
M.S. González-Huezo, A. Rojas-Sánchez, A.A. Rosales-Solís, R.M. Miranda-Cordero, A. Hinojosa-Ruiz, E. Mejía-García, E.G. Cruz-González. Frecuencia de erradicación del Helicobacter pylori con triple esquema convencional en pacientes adultos del Centro Médico Issemym. Revista de Gastroenterología de México 2012; 77(3): 114 doi: 10.1016/j.rgmx.2012.05.001
|
| 63 |
Vincenzo De Francesco, Angelo Zullo, Floriana Giorgio, Ilaria Saracino, Cristina Zaccaro, Cesare Hassan, Enzo Ierardi, Alfredo Di Leo, Giulia Fiorini, Valentina Castelli, Giovanna Lo Re, Dino Vaira. Change of point mutations in Helicobacter pylori rRNA associated with clarithromycin resistance in Italy.
Journal of Medical Microbiology
2014; 63(3): 453 doi: 10.1099/jmm.0.067942-0
|
| 64 |
L. G. Vologzanina, O. A. Igumnova, I. V. Petuhova. Effectiveness of eradication therapy for Hp infection of residents of Perm and the Perm region. Experimental and Clinical Gastroenterology 2023; (6): 14 doi: 10.31146/1682-8658-ecg-214-6-14-21
|
| 65 |
Ian H. Windham, D. Scott Merrell. Analysis of fitness costs associated with metronidazole and amoxicillin resistance in Helicobacter pylori. Helicobacter 2020; 25(5) doi: 10.1111/hel.12724
|
| 66 |
Tarik Aanniz, Wissal Bakri, Safae El Mazouri, Hajar Wakrim, Ilham Kandoussi, Lahcen Belyamani, Mouna Ouadghiri, Azeddine Ibrahimi. Focus on Bacterial Biofilms. 2022; doi: 10.5772/intechopen.104568
|
| 67 |
Angelo Zullo, Giuseppe Scaccianoce, Vincenzo De Francesco, Valentina Ruggiero, Pasquale D’Ambrosio, Luigi Castorani, Leonilde Bonfrate, Lucy Vannella, Cesare Hassan, Piero Portincasa. Concomitant, sequential, and hybrid therapy for H. pylori eradication: A pilot study. Clinics and Research in Hepatology and Gastroenterology 2013; 37(6): 647 doi: 10.1016/j.clinre.2013.04.003
|
| 68 |
Lingling Wang, Haobin Yao, Teresa Tong, KamShing Lau, Suet Yi Leung, Joshua W. K. Ho, Wai K. Leung. Dynamic changes in antibiotic resistance genes and gut microbiota after Helicobacter pylori eradication therapies. Helicobacter 2022; 27(2) doi: 10.1111/hel.12871
|
| 69 |
Tran Thanh Binh, Rumiko Suzuki, Tran Thi Huyen Trang, Dong Hyeon Kwon, Yoshio Yamaoka. Search for Novel Candidate Mutations for Metronidazole Resistance in Helicobacter pylori Using Next-Generation Sequencing. Antimicrobial Agents and Chemotherapy 2015; 59(4): 2343 doi: 10.1128/AAC.04852-14
|
| 70 |
Le Guo, Dantong Hong, Shue Wang, Fan Zhang, Feng Tang, Tao Wu, Yuankui Chu, Hongpeng Liu, Meng He, Hua Yang, Runting Yin, Kunmei Liu. Therapeutic Protection Against H. pylori Infection in Mongolian Gerbils by Oral Immunization With a Tetravalent Epitope-Based Vaccine With Polysaccharide Adjuvant. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.01185
|
| 71 |
Carol Thomas, Christopher D. Gwenin. The Role of Nitroreductases in Resistance to Nitroimidazoles. Biology 2021; 10(5): 388 doi: 10.3390/biology10050388
|
| 72 |
Nagendran Tharmalingam, Jenna Port, Dawilmer Castillo, Eleftherios Mylonakis. Repurposing the anthelmintic drug niclosamide to combat Helicobacter pylori. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-22037-x
|
| 73 |
Jose Danilo Atehortua Rendon, Tania Liseth Pérez Cala, Alonso Martínez. Descripción de la resistencia de Helicobacter pylori a seis antibióticos de uso frecuente en Colombia. Revista Colombiana de Gastroenterología 2020; 35(3): 351 doi: 10.22516/25007440.493
|
| 74 |
Arshid Yousefi-Avarvand, Hamid Vaez, Mohsen Tafaghodi, Amir Hossein Sahebkar, Mohsen Arzanlou, Farzad Khademi. Antibiotic Resistance of Helicobacter pylori in Iranian Children: A Systematic Review and Meta-Analysis. Microbial Drug Resistance 2018; 24(7): 980 doi: 10.1089/mdr.2017.0292
|
| 75 |
Amin Talebi Bezmin Abadi. Helicobacter pylori treatment: New perspectives using current experience. Journal of Global Antimicrobial Resistance 2017; 8: 123 doi: 10.1016/j.jgar.2016.11.008
|
| 76 |
I‐Fan Tu, Jiahn‐Haur Liao, Feng‐Ling Yang, Nien‐Tsung Lin, Hong‐Lin Chan, Shih‐Hsiung Wu. Lon Protease Affects the RdxA Nitroreductase Activity and Metronidazole Susceptibility in Helicobacter pylori. Helicobacter 2014; 19(5): 356 doi: 10.1111/hel.12140
|
| 77 |
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations. PLOS ONE 2016; 11(12): e0166199 doi: 10.1371/journal.pone.0166199
|
| 78 |
Bahareh Attaran, Tahereh Falsafi, Nassim Ghorbanmehr. Effect of biofilm formation by clinical isolates of <i>Helicobacter pylori</i> on the efflux-mediated resistance to commonly used antibiotics. World Journal of Gastroenterology 2017; 23(7): 1163-1170 doi: 10.3748/wjg.v23.i7.1163
|
| 79 |
Meiliang Gong, Yingjie Han, Xuning Wang, Hongjin Tao, Fansen Meng, Baicun Hou, Benjamin B. Sun, Gangshi Wang. Effect of Temperature on Metronidazole Resistance in Helicobacter pylori. Frontiers in Microbiology 2021; 12 doi: 10.3389/fmicb.2021.681911
|
| 80 |
Wai Phyo Aung, Than Than Aye, Khin San Aye, Aye Mya Mya Kyaw.
Levofloxacin‐based
Helicobacter pylori
eradication in chronic dyspepsia
. GastroHep 2021; 3(6): 394 doi: 10.1002/ygh2.478
|
| 81 |
Xiao-Juan Zhang, Shu-Ying Feng, Zhi-Tao Li, Yan-Ming Feng. Expression ofHelicobacter pylori hspAGene inLactococcus lactisNICE System and Experimental Study on Its Immunoreactivity. Gastroenterology Research and Practice 2015; 2015: 1 doi: 10.1155/2015/750932
|
| 82 |
Ilaria Maria Saracino, Matteo Pavoni, Laura Saccomanno, Giulia Fiorini, Valeria Pesci, Claudio Foschi, Giulia Piccirilli, Giulia Bernardini, John Holton, Natale Figura, Tiziana Lazzarotto, Claudio Borghi, Berardino Vaira. Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter pylori. Antibiotics 2020; 9(5): 244 doi: 10.3390/antibiotics9050244
|
| 83 |
Monika Maria Biernat, Aldona Bińkowska, Łukasz Łaczmański, Paweł Biernat, Paweł Krzyżek, Grażyna Gościniak. Phenotypic and Genotypic Analysis of Resistant Helicobacter pylori Strains Isolated from Children with Gastrointestinal Diseases. Diagnostics 2020; 10(10): 759 doi: 10.3390/diagnostics10100759
|
| 84 |
Bahgat Fayed, Jayalakshmi Jagal, Roberta Cagliani, Reena A. Kedia, Amr Elsherbeny, Hulya Bayraktutan, Ghalia Khoder, Mohamed Haider. Co-administration of amoxicillin-loaded chitosan nanoparticles and inulin: A novel strategy for mitigating antibiotic resistance and preserving microbiota balance in Helicobacter pylori treatment. International Journal of Biological Macromolecules 2023; 253: 126706 doi: 10.1016/j.ijbiomac.2023.126706
|
| 85 |
Farideh Siavoshi, Parastoo Saniee, Reza Malekzadeh. Effective antimicrobial activity of rifabutin against multidrug‐resistant Helicobacter pylori. Helicobacter 2018; 23(6) doi: 10.1111/hel.12531
|
| 86 |
Tran Thanh Binh, Seiji Shiota, Rumiko Suzuki, Miyuki Matsuda, Tran Thi Huyen Trang, Dong Hyeon Kwon, Shun Iwatani, Yoshio Yamaoka. Discovery of novel mutations for clarithromycin resistance in Helicobacter pylori by using next-generation sequencing. Journal of Antimicrobial Chemotherapy 2014; 69(7): 1796 doi: 10.1093/jac/dku050
|
| 87 |
Naim Asyraf Rosli, Anis Rageh Al-Maleki, Mun Fai Loke, Sun Tee Tay, Mohd Salleh Rofiee, Lay Kek Teh, Mohd Zaki Salleh, Jamuna Vadivelu, Bashir Sajo Mienda. Exposure of Helicobacter pylori to clarithromycin in vitro resulting in the development of resistance and triggers metabolic reprogramming associated with virulence and pathogenicity. PLOS ONE 2024; 19(3): e0298434 doi: 10.1371/journal.pone.0298434
|
| 88 |
Toshihiro Nishizawa, Hidekazu Suzuki. Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing. Frontiers in Molecular Biosciences 2014; 1 doi: 10.3389/fmolb.2014.00019
|
| 89 |
Ian H. Windham, D. Scott Merrell, George O’Toole. Interplay between Amoxicillin Resistance and Osmotic Stress in Helicobacter pylori. Journal of Bacteriology 2022; 204(5) doi: 10.1128/jb.00045-22
|
| 90 |
Meltem Ayaş, Yeşim Gürol. Antibiotic Resistance of Helicobacter pylori in Turkey: A Systematic Review and Meta-Analysis. Microbial Drug Resistance 2023; 29(3): 96 doi: 10.1089/mdr.2022.0146
|
| 91 |
Tran Thanh Binh, Rumiko Suzuki, Dong Hyeon Kwon, Yoshio Yamaoka. Complete Genome Sequence of a Metronidazole-Resistant Helicobacter pylori Strain. Genome Announcements 2015; 3(2) doi: 10.1128/genomeA.00051-15
|
| 92 |
Masumi Okuda, Yingsong Lin, Chaochen Wang, Toshihiko Kakiuchi, Shogo Kikuchi. Metronidazole for Helicobacter pylori eradication therapy among children and adolescents in Japan: Overcoming controversies and concerns. Helicobacter 2019; 24(3) doi: 10.1111/hel.12575
|
| 93 |
Jennifer Li, Xian-Zhi Li. Efflux-Mediated Antimicrobial Resistance in Bacteria. 2016; : 489 doi: 10.1007/978-3-319-39658-3_19
|
| 94 |
Tahereh Falsafi, Azadeh Ehsani, Bahareh Attaran, Vahid Niknam. Association of hp1181 and hp1184 Genes With the Active Efflux Phenotype in Multidrug-Resistant Isolates of Helicobacter pylori. Jundishapur Journal of Microbiology 2016; 9(4) doi: 10.5812/jjm.30726
|
| 95 |
Kimberly Sánchez-Alonzo, Libnny Belmar, Cristian Parra-Sepúlveda, Humberto Bernasconi, Víctor L. Campos, Carlos T. Smith, Katia Sáez, Apolinaria García-Cancino. Antibiotics as a Stressing Factor Triggering the Harboring of Helicobacter pylori J99 within Candida albicans ATCC10231. Pathogens 2021; 10(3): 382 doi: 10.3390/pathogens10030382
|
| 96 |
Nicoline F. Tanih, Roland N. Ndip. Molecular Detection of Antibiotic Resistance in South African Isolates ofHelicobacter pylori. Gastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/259457
|